Leiden University Scholarly Publications

Search results

(1 - 6 of 6)

: Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study

: Long-term efficacy and safety of erenumab results from 64 weeks of the LIBERTY study

: Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful

: Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

: Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial

: Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial